Latest

FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market

Protagonist Therapeutics

FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market

In a landmark decision for the dermatology sector, the U.S. Food and Drug Administration (FDA) has officially approved ICOTYDE™ (icotrokinra), a first-of-its-kind oral peptide for the treatment of moderate-to-severe plaque psoriasis. Developed through a high-stakes collaboration between Protagonist Therapeutics (Nasdaq: PTGX) and Johnson & Johnson (NYSE: JNJ), the approval

By MarketMinute
Strategic Consolidation in the Mitten: Independent Bank Corporation to Acquire HCB Financial Corp in $70 Million Deal

Banking

Strategic Consolidation in the Mitten: Independent Bank Corporation to Acquire HCB Financial Corp in $70 Million Deal

In a move that underscores the accelerating consolidation of the American community banking sector, Grand Rapids-based Independent Bank Corporation (NASDAQ:IBCP) announced on March 18, 2026, a definitive agreement to acquire HCB Financial Corp. (OTCPK:HCBN), the parent company of Highpoint Community Bank. The $70.2 million transaction represents a

By MarketMinute
The $100 Billion Bet: How OpenAI’s Historic Capital Raise and Nvidia’s Blackwell Supercycle are Re-Engineering the Global Economy

NVIDIA

The $100 Billion Bet: How OpenAI’s Historic Capital Raise and Nvidia’s Blackwell Supercycle are Re-Engineering the Global Economy

SANTA CLARA, CA — As of March 23, 2026, the global race for artificial intelligence supremacy has entered a fever pitch, driven by two monumental forces: the absolute market dominance of NVIDIA (NASDAQ: NVDA) and its Blackwell architecture, and a staggering $100 billion fundraising initiative by OpenAI. This unprecedented influx of

By MarketMinute